Innovation. Clarity. Execution.  I  Exit History

Exit History.

Delivering Value

2024

Centessa

Centessa

Share sale

2022

MiroBio

MiroBio

Exited

2021

Axonics

Axonics

Share sale
Centessa

Centessa

IPO NASDAQ
Aura

Aura

IPO NASDAQ

2020

Acutus

Acutus

IPO NASDAQ
Axonics

Axonics

Share sale
Kandy

Kandy

Aquired by Bayer $875M + milestones

2019

CardiAQ

CardiAQ

Acquired by Edwards Lifesciences Corporation USD $400M
Axonics

Axonics

Share sale

2018

Iterum

Iterum

IPO NASDAQ
Axonics

Axonics

Share sale

2017

Conatus

Conatus

Share sale

2016

SEP

SEP

Acquired by Juno Aspire Pharma
Biocartis

Biocartis

IPO EURONEXT

2015

Biocartis

Biocartis

IPO EURONEXT
Cellnovo

Cellnovo

IPO EURONEXT
CardiAQ

CardiAQ

Milestone
UniQure

UniQure

Share sale

2014

Agenus

Agenus

4-Antibody acquired by Agenus
Algeta

Algeta

Acquired by Bayer USD $2.9B
UniQure

UniQure

IPO NASDAQ
Aravive

Aravive

IPO NASDAQ

2013

CN

CN

Acquired by British American Tobacco
Conatus

Conatus

IPO NASDAQ
Santarus

Santarus

Acquired by Salix Pharmaceuticals Inc. USD $2.6B

2012

Micromet

Micromet

NASDAQ. Acquired by Amgen USD$1.1b
Avila

Avila

Acquired by Celgene USD$350m + USD$575m milestones
EUSA

EUSA

Acquired by Jazz Pharmaceuticals USD$700m

2011

Cardiokine

Cardiokine

Acquired by Cornerstone

2010

Respivert

Respivert

Acquired by J&J

2009

Emergent

Emergent

Merged with Microscience

2008

Thiakis

Thiakis

Acquired by Wyeth Pharmaceuticals USD$150m

2007

Algeta

Algeta

IPO Oslo Børs

2006

Infinity

Infinity

NASDAQ
PowderMed

PowderMed

Acquired by Pfizer

The companies in which we have invested since the year 2006 have discovered and developed, fourteen approved medicines and products to the benefit of patients, physicians and our investors.

Portfolio

About

Leading Venture Investors
Learn More

Portfolio

Innovative Life Sciences Companies
Learn More